medigraphic.com
ISSN 1561-3054 (Electronic)

2021, Number 3

<< Back Next >>

Rev Cubana Med Trop 2021; 73 (3)

Reduction in invasive pneumococcal disease surveillance after the start of the COVID-19 pandemic, Cuba 2020

Toraño PGT, Barreto NB, Pérez FYC, Abreu CME

Language: Spanish
References: 11
Page: 1-6
PDF size: 250.93 Kb.


ABSTRACT

During the COVID-19 pandemic, surveillance systems for vaccine-preventable diseases should remain active. The purpose of the present communication is to warn about the weakening of invasive pneumococcal disease surveillance in Cuba during the year 2020. To achieve such an end, a retrospective analysis was conducted of the number of invasive pneumococcal disease cases confirmed at the Cuban National Reference Laboratory in the period 2014-2020. From 2014 to 2019 the number of Streptococcus pneumoniae isolates ranged between 81 and 121. In 2020 only 31 isolates were confirmed, 19 of which were retrieved from meningitis and a mere five from pneumonia. The health actions implemented to contain the spread of the COVID-19 pandemic may have influenced the decline in the number of isolated responsible for invasive pneumococcal disease. This situation seems to be a consequence of the weakening of surveillance, since COVID-19 diagnostic tests became a priority during 2020.


REFERENCES

  1. World Health Organization (WHO). Vaccine Preventable Diseases Surveillance Standard. [acceso: 01/12/2019]. Disponible en: Disponible en: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/standards/en/

  2. WHO Position Paper on Pneumococcal conjugate vaccines in infants and children under 5 years of age, February 2019 [Internet]. Geneva (Switzerland): World Health Organization; Feb 2019 [acceso: 01/12/2019]. Disponible en: Disponible en: https://apps.who.int/iris/bitstream/handle/10665/310968/WER9408.pdf?ua=1

  3. Linares-Pérez N. Team Science and Accelerated Vaccine Introduction in Cuba: A View from the Pneumococcal Project. MEDICC Review. 2019;21(1):37-8.

  4. Habib M, Porter BD, Satzke C. Capsular Serotyping of Streptococcus pneumoniae. Using the Quellung Reaction. J Vis Exp. 2014;(84):51208. Doi: https://doi.org/10.3791/51208

  5. Clinical and Laboratory Standard Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 29th ed. CLSI supplement M100. Wayne (Pennsylvania): Clinical and Laboratory Standards Institute; 2019.

  6. Pérez A, Dickinson F, Rodriguez M. Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infectious Diseases. 2010 [acceso: 01/12/2019];10:130. Disponible en: Disponible en: http://www.biomedcentral.com/1471-2334/10/130

  7. Toraño G, Pías L, Capote M, Rodríguez M, Dickinson F, Varcárcel M. Serotipos y resistencia antimicrobiana de aislamientos meníngeos de Streptococcus pneumoniae. Cuba, 2007-2012. Vacci Monitor. 2014;23(3):117-23.

  8. Galvin CJ, Li Y-CJ, Malwade S, Syed-Abdul S. COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan. Int J Infect Dis. 2020;98:18-20.

  9. Rachel HF Lim, Angela Chow, Hanley J Ho. Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore. J Infect. 2020;81(6):19-21.

  10. Sánchez C, Povea E, Ortega L, Núñez A. Infección respiratoria aguda antes y durante la pandemia COVID-19 y sus costos. Rev Cubana Pediatría. 2020;92(Supl. especial):e1305.

  11. Amin-Chowdhury Z, Aiano F, Mensah A, Sheppard C, Litt D, Fry N, Andrews N, Ramsay ME and Ladhani S. Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England. CID. 2021;72:65-75.




2020     |     www.medigraphic.com